Tag: anticoccidial drugs market forecast

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Anticoccidial Drugs Market Set To Climb From $1.44 Billion In 2026 To $1.84 Billion By 2030

The market for anticoccidial drugs has experienced robust expansion in recent years. It is forecast to grow from $1.35 billion in 2025 to $1.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical growth of this market stemmed from the significant prevalence of coccidiosis in poultry, a restricted range of effective drug classes, an increasing demand for livestock products, adherence to traditional farming practices, and a rising recognition of animal health management.

The anticoccidial drugs market is projected to experience substantial expansion in the coming years, reaching a valuation of $1.84 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This anticipated growth is driven by factors such as advancements in drug delivery systems, the increasing prevalence of intensive poultry farming, the broadening of veterinary services in developing areas, enhanced governmental backing for animal health initiatives, and a rise in worldwide meat and poultry consumption. Key trends identified for this period encompass the creation of new anticoccidial drug formulations, a heightened emphasis on managing poultry health, a growing preference for combination therapies, the enlargement of veterinary pharmaceutical distribution channels, and stricter regulatory adherence for veterinary medications.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anticoccidial Drugs Market Growth Backed By Core Demand Fundamentals

The anticoccidial drug market is anticipated to expand, driven by the increasing need for meat proteins. These proteins, naturally found in animal tissue, consist of various amino acids vital for numerous physiological processes. Factors contributing to this rising demand include a growing global population, higher discretionary income, urban expansion, and evolving dietary habits favoring protein-dense foods. In contemporary livestock farming, anticoccidial medications are vital for preserving animal well-being and productivity, allowing producers to fulfill the increasing requirement for meat proteins effectively and responsibly. For example, as reported by the Australia-based non-profit organization Meat And Livestock Australia Limited in October 2025, Australia saw its red meat and livestock exports grow by 3.2% year-on-year in 2024, achieving a total value of $19.5 billion. Consequently, the expanding consumption of meat proteins is fueling the development of the anticoccidial drug market.

Anticoccidial Drugs Market Segment Analysis And Revenue Potential

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Anticoccidial Drugs Market Growth Trends Reshaping The Competitive Landscape

Major companies operating in the anticoccidial drugs market are focusing on developing innovative solutions, such as synthetic coccidiostat, to improve efficacy, minimize the development of resistance, and address evolving challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound utilized to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For instance, in March 2023, Zoetis, a US-based animal health company, launched Avi-Deccox, a reformulated synthetic coccidiostat designed for coccidiosis control in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for significant economic losses in poultry farming. This product features decoquinate as its active ingredient, similar to its predecessor, Deccox. Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by employing a different mode of action, providing a more effective short-term knock-down effect.

Anticoccidial Drugs Market Key Players Shaping Industry Direction

Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition

View The Full Anticoccidial Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anticoccidial Drugs Market Geographic Spread And Regional Opportunities

North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Anticoccidial Drugs Market Value Analysis: What Growth Is Expected Over The Forecast Period?

Recent years have seen significant expansion in the anticoccidial drugs market, which is projected to increase from $1.35 billion in 2025 to $1.45 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.9%. This past growth has been driven by factors such as the elevated occurrence of coccidiosis in poultry, a constrained selection of effective drug classes, a surge in demand for livestock products, reliance on conventional farming approaches, and growing recognition of the importance of animal health management.

The anticoccidial drugs market is projected to experience substantial growth over the coming years, with an anticipated increase to $1.84 billion by 2030, reflecting a compound annual growth rate of 6.2%. This expansion during the forecast period is driven by advancements in drug delivery systems, the intensification of poultry farming operations, the widening availability of veterinary services in developing regions, enhanced governmental backing for animal health initiatives, and rising global consumption of meat and poultry products. Key developments shaping the market landscape include the creation of innovative anticoccidial drug formulations, a heightened emphasis on managing poultry health, a growing preference for combination therapies, the broadening of veterinary pharmaceutical supply networks, and stricter adherence to regulatory standards for veterinary medications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Anticoccidial Drugs Market Demand Drivers: What Is Fueling Industry Growth?

The increasing consumption of meat proteins is anticipated to boost the anticoccidial drug market in the coming period. Meat proteins, naturally occurring in animal tissues, supply essential amino acids needed for various physiological processes. This heightened demand stems from factors like population expansion, higher disposable incomes, urban development, and evolving dietary habits favoring protein-rich options. Anticcocidial drugs serve as critical components in contemporary animal husbandry, aiding in preserving animal health and productivity to enable farmers to meet surging meat protein needs effectively and sustainably. By October 2025, Meat and Livestock Australia Limited—an Australian nonprofit—reported that in 2024, the nation’s red meat and livestock exports saw a 3.2% year-over-year increase, hitting a value of $19.5 billion. Consequently, the rising appetite for meat proteins is fueling expansion in the anticoccidial drug market.

Anticoccidial Drugs Market Driver: Poultry Farming Surge Drives Anticoccidial Drug Market Growth

An uptick in poultry farming is set to accelerate growth within the anticoccidial drug market moving forward. Poultry farming involves raising domesticated fowl, including chickens, turkeys, ducks, and geese, for meat, eggs, and feather production. This growth in poultry operations is driven by greater protein demand, advancements in farming methods, and an increase in global trade. Anticcocidial drugs are frequently incorporated into poultry feed or water as a precautionary approach, shielding birds from coccidiosis during their early, most susceptible growth phases. In April 2024, as reported by the USDA Economic Research Service—a US government agency—the number of chickens sold in 2023 reached 178 million, representing a 4% rise from the prior year, with turkey numbers also climbing by 4%. Thus, the expansion of poultry farming is propelling the anticoccidial drug market forward.

Anticoccidial Drugs Market Categorization By Product Type And Application

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Anticoccidial Drugs Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading industry players in the anticoccidial drugs market prioritize the creation of advanced solutions, including synthetic coccidiostats, to improve effectiveness, reduce the risk of resistance, and tackle evolving issues in poultry and livestock management. A synthetic coccidiostat is a chemically formulated substance that prevents or manages coccidiosis by stopping the growth and reproduction of coccidia parasites within animals. As an example, in March 2023, Zoetis, an animal health firm headquartered in the US, introduced Avi-Deccox, a newly developed synthetic coccidiostat aimed at managing coccidiosis in broiler chickens. This formulation is specifically directed at the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for substantial financial setbacks in poultry operations. The product utilizes decoquinate as its key component, much like its earlier version, Deccox. By utilizing an alternative mechanism of action, Avi-Deccox counteracts the growing problem of resistance associated with the routine use of ionophores in poultry farming, delivering a more potent short-term knock-down impact.

Anticoccidial Drugs Market Company Landscape And Strategic Competition

Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition

Access The Complete Anticoccidial Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Anticoccidial Drugs Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Anticoccidial Drugs Market Be By 2030 Compared To Its 2026 Market Size?

The anticoccidial drugs market has experienced robust expansion in recent years. It is projected to increase from $1.35 billion in 2025 to $1.45 billion in 2026, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this historical growth include a high prevalence of coccidiosis in poultry, limited availability of effective drug classes, growing demand for livestock products, traditional farming practices, and increasing awareness of animal health management.

The market for anticoccidial drugs is projected to experience substantial expansion over the upcoming years. This market is set to reach $1.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period stems from factors such as advancements in drug delivery systems, an increase in intensive poultry farming practices, the broadening of veterinary services in developing areas, heightened governmental backing for animal well-being, and a rise in worldwide meat and poultry consumption. Key trends anticipated during this period encompass the creation of new anticoccidial drug formulations, a greater emphasis on poultry health management, the growing embrace of combination treatments, an expansion of distribution networks for veterinary pharmaceuticals, and improved regulatory adherence for veterinary medications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Key Drivers Are Affecting The Anticoccidial Drugs Market Development?

The growing demand for meat proteins is expected to propel the growth of the anticoccidial drug market going forward. Meat proteins are naturally present in animal flesh, comprising various amino acids essential for various bodily functions. The rising demand for meat proteins is due to population growth, increasing disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are essential tools in modern livestock farming. They help maintain the health and productivity of animals, ensuring that farmers can meet the growing demand for meat proteins efficiently and sustainably. For instance in October 2025 according to the Meat And Livestock Australia Limited a Australia-based non-profit organization in 2024, Australia’s red meat and livestock exports increased by 3.2% year-on-year, reaching a value of $19.5 billion. Therefore, the growing demand for meat proteins is driving the growth of the anticoccidial drug market. The rise in poultry farming is expected to propel the growth of the anticoccidial drug market going forward. Poultry farming refers to raising domesticated birds, such as chickens, turkeys, ducks, and geese, to produce meat, eggs, and feathers. The rise in poultry farming is due to increasing demand for protein, improved farming techniques, and the expansion of global trade. Anticoccidial drugs are often added to poultry feed or water as a preventive measure to protect the birds from coccidiosis during the early and most vulnerable stages of growth. For instance, in April 2024, according to the USDA Economic Research Service, a US-based government administration, in 2023, the number of chickens sold totaled 178 million, up 4 percent from the previous year, and turkey numbers increased by 4 percent as well. Therefore, the rise in poultry farming is driving the growth of the anticoccidial drug market.

What Segment Categories Shape The Anticoccidial Drugs Market Segment Landscape?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Which Trends Are Guiding The Direction Of The Anticoccidial Drugs Market?

Leading companies operating in the anticoccidial drugs market are concentrating on developing innovative solutions, such as synthetic coccidiostats, to enhance efficacy, minimize resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound utilized to prevent or control coccidiosis by impeding the growth and reproduction of coccidia parasites in animals. For instance, in March 2023, Zoetis, a US-based animal health company, introduced Avi-Deccox, a reformulated synthetic coccidiostat specifically designed to manage coccidiosis in broiler chickens. This product particularly targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for significant economic losses in poultry farming. Its active ingredient is decoquinate, mirroring that of its forerunner, Deccox. Avi-Deccox tackles the increasing problem of resistance associated with the frequent use of ionophores in poultry farming by employing an alternative mode of action, thereby offering a more effective short-term knock-down effect.

Who Are The Companies Operating Across The Anticoccidial Drugs Market Value Chain?

Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition

Get The Full Anticoccidial Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Which Region Is The Leading Market For The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anticoccidial Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2026, By The Business Research Company

Anticoccidial Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Anticoccidial Drugs Market During The Forecast Period 2026–2030?

The anticoccidial drugs market size has experienced robust growth in recent years. It is forecast to expand from $1.35 billion in 2025 to $1.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historic period can be attributed to several factors, including the high prevalence of coccidiosis in poultry, the limited availability of effective drug classes, increasing demand for livestock products, traditional farming practices, and a growing awareness of animal health management.

The anticoccidial drugs market is projected to experience robust expansion over the coming years, with its size anticipated to reach $1.84 billion by 2030, showing a compound annual growth rate (CAGR) of 6.2%. This projected growth is driven by several factors, including advancements in drug delivery systems, the surge in intensive poultry farming, the expansion of veterinary services across developing regions, greater government backing for animal health initiatives, and the increasing worldwide consumption of meat and poultry. Furthermore, significant trends during this period are expected to encompass the creation of new anticoccidial drug formulations, a heightened emphasis on poultry health management, the growing use of combination therapies, the broadening of veterinary pharmaceutical distribution channels, and stricter regulatory adherence for veterinary medications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Major Factors Are Driving The Expansion Of The Anticoccidial Drugs Market?

The expanding requirement for meat proteins is anticipated to fuel the growth of the anticoccidial drug market in the future. Meat proteins, which are naturally found in animal tissues, consist of various amino acids vital for numerous bodily functions. This increasing need for meat proteins stems from factors such as global population expansion, higher disposable incomes, urbanization trends, and evolving dietary preferences favoring protein-rich diets. Anticoccidial medications serve as critical instruments in contemporary livestock cultivation, assisting in preserving animal well-being and output. This ensures that producers can effectively and sustainably satisfy the rising need for meat proteins. As an illustration, in October 2025, the Meat And Livestock Australia Limited, an Australia-based non-profit organization, reported that Australia’s red meat and livestock exports saw a 3.2% year-on-year increase in 2024, reaching a total value of $19.5 billion. Consequently, the escalating demand for meat proteins is a primary impetus behind the expansion of the anticoccidial drug market.

What Market Segments Are Evaluated Within The Anticoccidial Drugs Market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

What Industry Trends Are Redefining The Anticoccidial Drugs Market?

Major companies within the anticoccidial drugs market are concentrating on creating advanced solutions, such as synthetic coccidiostat, to boost effectiveness, minimize the development of resistance, and tackle emerging issues in poultry and livestock management. A synthetic coccidiostat is a chemically engineered substance employed to prevent or control coccidiosis by inhibiting the proliferation and growth of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health company based in the US, introduced Avi-Deccox, a redeveloped synthetic coccidiostat aimed at managing coccidiosis in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for substantial financial losses in poultry farming. Its active ingredient is decoquinate, mirroring its earlier version, Deccox. Avi-Deccox tackles the increasing problem of resistance linked to the common application of ionophores in poultry farming by utilizing a distinct mechanism of action, thereby providing a more potent short-term knock-down effect.

Who Are The Top Market Participants Influencing The Anticoccidial Drugs Market?

Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition

Read the full anticoccidial drugs market report here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Which Region Currently Holds The Largest Share Of The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anticoccidial Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2026, By The Business Research Company

Anticoccidial Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the anticoccidial drugs market from 2026–2035 with trusted insights from The Business Research Company

How is the Anticoccidial Drugs Market size predicted to change over the forecast window of 2026–2035?

The anticoccidial drugs market size has demonstrated strong expansion in recent years. It is anticipated to increase from $1.35 billion in 2025 to $1.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical growth of this market can be linked to the high prevalence of coccidiosis in poultry, the limited availability of effective drug classes, a growing demand for livestock products, traditional farming practices, and increasing awareness of animal health management.

The anticoccidial drugs market size is projected to experience robust expansion in the coming years. This market is anticipated to reach a size of $1.84 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this anticipated growth include advancements in drug delivery systems, the surge in intensive poultry farming practices, the broadening of veterinary services across developing areas, heightened governmental backing for animal well-being, and an increase in worldwide meat and poultry consumption. Key trends during this period are expected to encompass the creation of new anticoccidial drug formulations, a greater emphasis on managing poultry health, a growing uptake of combination treatment approaches, the enlargement of distribution networks for veterinary pharmaceuticals, and improved adherence to regulations for veterinary medicines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Drivers Are Contributing To The Expansion Of The Anticoccidial Drugs Market?

The escalating need for meat proteins is projected to drive the expansion of the anticoccidial drug market moving forward. These proteins are naturally present in animal flesh, supplying essential amino acids required for various bodily functions. The heightened demand for meat proteins results from factors like population growth, increased disposable income, urbanization, and a shift in dietary preferences towards protein-rich foods. Anticoccidial drugs play a vital role in contemporary livestock farming, supporting animal health and productivity to help farmers efficiently and sustainably meet this rising demand for meat proteins. For example, in October 2025, as reported by Meat And Livestock Australia Limited, an Australia-based non-profit organization, Australia’s red meat and livestock exports grew by 3.2% year-on-year in 2024, reaching a value of $19.5 billion. Thus, the increasing requirement for meat proteins is a key factor propelling the growth of the anticoccidial drug market.

What Segment Categories Are Covered In The Anticoccidial Drugs Market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

What Trends Are Reshaping The Dynamics Of The Anticoccidial Drugs Market?

Leading companies in the anticoccidial drugs market are focused on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, minimize the development of resistance, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound utilized to prevent or control coccidiosis by hindering the growth and reproduction of coccidia parasites in animals. For instance, in March 2023, Zoetis, a US-based animal health company, launched Avi-Deccox, a reformulated synthetic coccidiostat designed for coccidiosis control in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for considerable economic losses in poultry farming. The product features decoquinate as its active ingredient, similar to its predecessor, Deccox. Avi-Deccox addresses the escalating issue of resistance linked to the frequent use of ionophores in poultry farming by employing a different mode of action, thereby providing a more effective short-term knock-down effect.

Which Major Industry Participants Are Leading The Anticoccidial Drugs Market Growth?

Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anticoccidial Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2026, By The Business Research Company

Anticoccidial Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the anticoccidial drugs market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Anticoccidial Drugs Industry By 2029?

The anticoccidial drugs market has witnessed robust expansion in recent years. It is projected to increase from $1.27 billion in 2024 to $1.35 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.6%. The historical growth of this market can be attributed to a rise in coccidiosis cases globally, increased adoption of pet animals, the high prevalence of coccidiosis, its economic impact, and growing concerns about the safety of food and health of animals.

The anticoccidial drugs market is anticipated to experience robust expansion over the next few years, with its size projected to reach “$1.75 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is primarily attributed to the expanding availability of veterinary healthcare, the increasing occurrence of coccidiosis in animals, the growing adoption of synthetic drugs, the rising need for feed additives, and increased livestock production. Significant trends influencing the market in this period include a heightened demand driven by emerging coccidiosis strains, a discernible move towards natural and alternative treatment approaches, enhanced regulatory scrutiny fostering innovation, evolving consumer preferences for antibiotic-free poultry products, continuous advancements in drug delivery technologies, an intensified focus on preventive healthcare strategies, and the broadening of applications into aquaculture and companion animal sectors.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

What Major Drivers Are Impacting The Anticoccidial Drugs Market?

The increasing need for meat proteins is anticipated to drive the expansion of the anticoccidial drug market in the future. These proteins are naturally found in animal tissue and consist of diverse amino acids vital for numerous physiological processes. This escalating demand for meat proteins stems from factors such as population expansion, higher disposable incomes, urban development, and evolving dietary habits favoring protein-dense meals. Anticoccidial medications serve as crucial instruments in contemporary animal agriculture. They contribute to sustaining animal health and productivity, enabling farmers to effectively and sustainably satisfy the increasing requirement for meat proteins. As an illustration, a report released in July 2023 by the Organization for Economic Co-operation and Development (OECD), an intergovernmental body based in France, and the Food and Agriculture Organization, a specialized agency from Italy, indicated that while global average per capita meat demand was forecast to rise by 2% from the 2020-2022 baseline to 2032, the FAO meat price index actually climbed by 10% in 2022, attributed to reduced export availability. Consequently, the expanding demand for meat proteins is fueling the advancement of the anticoccidial drug market.

Which Segment Categories Are Driving Maximum Growth In The Anticoccidial Drugs Market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Which Long-Term Trends Will Play A Crucial Role In The Anticoccidial Drugs Market?

Companies operating in the anticoccidial drugs market are concentrating on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, minimize the development of resistance, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound employed to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For instance, in March 2023, Zoetis, a US-based animal health company, launched Avi-Deccox, a reformulated synthetic coccidiostat designed to manage coccidiosis in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for significant economic losses in poultry farming. This product incorporates decoquinate as its active ingredient, similar to its predecessor, Deccox. Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by employing a different mode of action, providing a more effective short-term knock-down effect.

Who Are The Dominant Players In The Anticoccidial Drugs Market Today?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Which Region Is At The Forefront Of Innovation In The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2025, By The Business Research Company

Bladder Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Anticoccidial Drugs Market?

In recent times, the market size for anticoccidial drugs has seen robust growth. There is a projection that it will upscale from $1.27 billion in 2024 to $1.35 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.6%. The past expansion is linked to a worldwide spike in coccidiosis cases, greater acceptance of pet animals, high occurrences of coccidiosis, economic influences, and heightened worry over food and animal health safety.

The market for anticoccidial drugs is set to witness robust expansion over the coming years, with projections estimating a surge to “$1.75 billion by 2029,” marking an annual growth rate of 6.5%. This expected growth during the forecast period is credited to various factors including an increase in veterinary healthcare, the growing incidence of coccidiosis in animals, escalated use of synthetic drugs, rising demand for feed additives, and an uptick in livestock production. Trends for the forecast period signal a boost in demand due to new coccidiosis strains, a tilt towards organic and alternate treatment approaches, amplified regulatory scrutiny stimulating innovative practices, growing consumer inclination towards poultry products free of antibiotics, advances in drug delivery methods, enhanced emphasis on preventive healthcare initiatives, and widened use in aquaculture and pet animal sectors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

What Drivers Are Accelerating Expansion Of The Anticoccidial Drugs Market?

The expansion of the anticoccidial drug market is projected to be fuelled by the surge in meat protein demand. These proteins, found naturally in animal flesh, consist of numerous vital amino acids necessary for various bodily functioning. Population rise, enhanced disposable income, urban growth, and a shift in dietary choices towards protein-dense food are all contributing to the uptick in meat protein demand. Anticoccidial drugs play a significant role in today’s livestock farming, helping maintain animal health and productivity and enabling farmers to fulfil the increasing meat protein demand effectively and sustainably. For example, a report released in July 2023 by the France-based Organization for Economic Co-operation and Development (OECD) and Italy’s specialized Food and Agriculture Organization agency revealed that despite a predicted 2% rise in global average per capita meat demand between 2020-2022 and 2032, the FAO meat price index escalated by 10% in 2022 due to depleted export supplies. Thus, the rising demand for meat proteins is propelling the growth of the anticoccidial drug market.

What Are The Primary Segmentation Parameters In The Anticoccidial Drugs Market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Which Emerging Trends Are Reshaping The Anticoccidial Drugs Market Landscape?

Primary players in the anticoccidial drugs market, like Zoetis, are concentrating their efforts on creating novel products such as synthetic coccidiostats. The aim is to augment efficacy, curb the occurrence of resistance, and tackle new issues in poultry and livestock care. Synthetic coccidiostats are specially made compounds that deter or manage coccidiosis by impeding the growth and reproduction of coccidia parasites in animals. For instance, Zoetis, an animal health company based in the US, released Avi-Deccox in March 2023. This newly reformulated synthetic coccidiostat is engineered to control coccidiosis in broiler chickens, specifically targeting the pathogens Eimeria acervulina and Eimeria tenella, associated with major financial setbacks in poultry farming. Just like its predecessor, Deccox, the primary active component in Avi-Deccox is decoquinate. By utilising a different action mode, Avi-Deccox offers a more effective short-term resolution to the increasing problem of resistance associated with the prevalent use of ionophores in poultry farming.

Who Are The Dominant Players In The Anticoccidial Drugs Market Today?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What Are The Emerging Regional Trends Driving The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Anticoccidial Drugs Market Valued at Present and by 2029?

In recent times, the market size for anticoccidial drugs has been on a steady incline. Approximately, the market value will increase from $1.27 billion in 2024 to $1.35 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The notable growth during the historic period can be linked to several factors such as the worldwide surge in coccidiosis cases, a rise in pet ownership, a high occurrence rate of coccidiosis, economic ramifications, and escalated worries about the health and food safety of animals.

The market for anticoccidial drugs is poised for significant expansion in the approaching years, projected to reach a worth of “$1.75 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.5%. Various factors fueling this predicted growth include the increase in veterinary healthcare, the escalating incidences of coccidiosis in animals, the proliferation in the usage of synthetic drugs, the rising demand for feed additives, and enhancing livestock production. Key trends that will define this timeframe include a heightened demand due to new strains of coccidiosis, a shift towards natural and alternative treatment strategies, spurred innovation due to rigorous regulatory oversight, elevated consumer desire for poultry products free of antibiotics, advancements in drug administration techniques, a sharper focus on preventative healthcare measures, and new applications in the aquaculture and companion animal sectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

#What Drivers Are Influencing Growth In The Anticoccidial Drugs Market?

The escalation in the need for meat proteins is anticipated to boost the anticoccidial drug market’s expansion in the future. Naturally found in animal flesh, meat proteins consist of diverse essential amino acids for various metabolic processes. The surge in demand for these proteins is attributed to population growth, increased disposable income, urbanization, and a shift in dietary preferences towards food rich in proteins. Anticoccidial pharmaceuticals play a crucial role in modern livestock farming; they aid in preserving the health and productivity of animals, enabling farmers to cater to the escalating demand for meat proteins effectively and sustainably. As an illustration, in July 2023, a report by the France-based intergovernmental organization, the Organization for Economic Co-operation and Development (OECD), and the Food and Agriculture Organization, an Italy-based specialized agency, noted that, opposed to the anticipated 2% rise in global average per capita meat demand from 2020-2022 to 2032, the FAO meat price index skyrocketed by 10% in 2022 owing to reduced export supplies. Consequently, the surging demand for meat proteins fuels the growth of the anticoccidial drug market.

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

What Upcoming Trends Are Expected To Impact The Anticoccidial Drugs Market Globally?

Leading corporations in the anticoccidial drugs market are concentrating on creating novel solutions like synthetic coccidiostats. These solutions aim to augment effectiveness, reduce the development of resistance, and meet the rising complications in poultry and livestock management. Synthetic coccidiostat, a specially crafted chemical compound, is aimed at controlling or preventing coccidiosis by restricting the growth and duplication of coccidia parasites in the animals. For instance, in March 2023, Avi-Deccox, a revamped synthetic coccidiostat was launched by Zoetis, a US-based animal health corporation. The product is intended to check coccidiosis in broiler chickens specifically, while primarily targeting the Eimeria acervulina and Eimeria tenella pathogens, associated with substantial financial losses in poultry farming. The active ingredient in this product, similar to its precursor, Deccox, is decoquinate. By using a unique mode of action, Avi-Deccox manages the escalating problem of resistance resulting from the regular usage of ionophores in poultry farming and offers a more efficacious immediate effect.

Which Companies Play A Key Role In The Development Of The Anticoccidial Drugs Market?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What Are The Key Regional Developments Shaping The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Anticoccidial Drugs Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

In recent times, the anticoccidial drugs market has seen a robust expansion. The market’s value which was at $1.27 billion in 2024, is projected to rise to $1.35 billion in 2025, recording a compound annual growth rate (CAGR) of 6.6%. The surge witnessed in the previous term can be ascribed to the escalated occurrence of coccidiosis worldwide, a rise in the adoption of pets, an increased prevalence of coccidiosis, economic implications, and heightened safety considerations regarding the nourishment and wellbeing of animals._x000D_

_x000D_

Expectations are high for significant expansion in the anticoccidial drugs market in the coming years. It’s projected to reach a value of $1.75 billion in 2029, with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this predicted growth within the forecast period include the expanding veterinary healthcare sector, the increasing incidence of coccidiosis in animals, a rise in the usage of synthetic drugs, a surge in demand for feed additives, and a boom in livestock production. The period ahead is also anticipated to see a rise in demand due to the emergence of new strains of coccidiosis, a move towards natural and alternative treatment options, boosted innovation due to tighter regulatory control, increasing consumer preference for poultry products without any antibiotics, advancements in drug delivery technology, an increased emphasis on preventive health measures and the broadening scope of applications in aquaculture and companion animal sectors._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp_x000D_

_x000D_

#What Are the Core Growth Drivers Propelling the Anticoccidial Drugs Market Forward?#_x000D_

The anticoccidial drug market is poised for growth, propelled by the increasing demand for meat proteins. Animal flesh naturally contains meat proteins, including various vital amino acids necessary for bodily functions. The escalating demand can be attributed to population growth, elevated disposable income, urbanization, and a shift in dietary preferences towards foods high in protein. In modern livestock farming, anticoccidial drugs play a crucial role. They are vital for the well-being and productivity of animals, empowering farmers to fulfil the meat protein demand sustainably and efficiently. As reported in July 2023, by the France-based Organisation for Economic Co-operation and Development (OECD) and Italy-based Food and Agriculture Organization, while the global average per capita meat demand is expected to rise by 2% from the 2020-2022 base period to 2032, the FAO meat price index experienced a 10% leap in 2022 due to reduced export supplies. Thus, the mounting demand for meat proteins is catalyzing the expansion of the anticoccidial drug market._x000D_

_x000D_

#What Segment Types Define the Anticoccidial Drugs Market Structure?#_x000D_

The anticoccidial drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes_x000D_

2) By Drug Action: Coccidiostatic, Coccidiocidal_x000D_

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals_x000D_

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels_x000D_

_x000D_

Subsegments:_x000D_

1) By Ionophore: Monensin, Lasalocid, Salinomycin _x000D_

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin _x000D_

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline _x000D_

4) By Chemical Derivative: Diclazuril, Clopidol _x000D_

5) By Other Drug Classes: Amprolium, Robenidine_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Anticoccidial Drugs Market?#_x000D_

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Which Emerging Trends that Are Influencing theAnticoccidial Drugs Industry Evolution?#_x000D_

Leading firms in the anticoccidial drugs market are concentrating on creating novel solutions, such as synthetic coccidiostat, to improve effectiveness, reduce the risk of resistance development, and overcome new hurdles in poultry and livestock management. Synthetic coccidiostat is a chemically designed substance that curbs coccidiosis by hindering the growth and multiplication of the coccidia parasites in animals. For example, in March 2023, Zoetis, an American animal health company, rolled out Avi-Deccox, a synthetic coccidiostat with improved formulation aimed to control coccidiosis in broiler chickens. This product specifically combats Eimeria acervulina and Eimeria tenella pathogens, the culprits behind significant economic damages in poultry farming. Much like its earlier version, Deccox, the active ingredient in this product is decoquinate. Avi-Deccox responds to the increasing problem of resistance related to the regular use of ionophores in poultry farming by adopting a different mechanism of action, offering a more efficient immediate knock-down effect._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report_x000D_

_x000D_

#What Is the Definition of the Anticoccidial Drugs Market?#_x000D_

Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model